Adverse influence of numbers of previous miscarriages on results of paternal lymphocyte immunization in patients with recurrent spontaneous abortions

American Journal of Reproductive Immunology

Volumn 44, Issue 5, 2000, Pages 289-292

  Katano, Kinue ^a   Aoki, Koji ^b   Ogasawara, Mayumi Sugiura ^a   Suzumori, Kaoru ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Nagoya City Josai Hospital   (Japan)

Author keywords

Number of previous miscarriages; Paternal lymphocyte immunotherapy; Recurrent spontaneous abortions

Indexed keywords

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE; MAJOR CLINICAL STUDY; PATERNITY; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECURRENT ABORTION; RISK FACTOR; SPONTANEOUS ABORTION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033660437     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2000.440507.x     Document Type: Article

References (6)

1. Taylor CG, Faulk WP: Prevention of recurrent abortion with leucocyte transfusions. Lancet 1981; ii:68-69.
2. Mowbray JF, Gibbings C, Liddle H, Reginald PW, Underwood JL, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985; i:941-943.
3. Ho HN, Gill TJ III, Hsieh HJ, Jiang JI, Lee TY, Hsieh CY: Immunotherapy for recurrent spontaneous abortions in a Chinese population. Am J Reprod Immunol 1991; 25:10-15.
4. The Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
5. Jeng GT, Scott JR, Burmeister LF: A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA 1995; 274(10):830-836.
6. Clark DA, Daya S, Coulam CB, Gunby J, and Recurrent Miscarriage Immunotherapy Trialists Group. Implication of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996;35:495-498.